Physician profile
Esther Finney
NPI 1093108680
$1,179.28
in general payments reported to CMS, 2019-2025
18 companies · $839 in 2025
The $839 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $340 · 2025: $839.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,179.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,179.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $344.46 | 2024-2025 | Ams 700, Ams 800 Artificial Urinary Sphincter, Watchman Access System |
| Laborie Medical Technologies Corp. | $147.20 | 2025 | Optilume Bph Drug Coated Balloon Catheter |
| Pfizer INC. | $97.23 | 2024-2025 | |
| Srs Medical Systems, INC. | $95.19 | 2024 | Ct3000 Pro Base Unit, Urocuff-Dc Disposable, Single |
| Calyxo, INC. | $93.00 | 2025 | Cvac Aspiration System |
| Bayer Healthcare Pharmaceuticals INC. | $71.61 | 2024-2025 | |
| Axonics, INC. | $62.87 | 2024 | Axonics |
| Medtronic, INC. | $41.73 | 2024-2025 | Altaviva, Interstim |
| Janssen Biotech, INC. | $27.82 | 2024 | Erleada |
| Ambu INC. | $26.14 | 2024 | |
| Tolmar, INC. | $24.68 | 2025 | Eligard, Jatenzo |
| Ferring Pharmaceuticals INC. | $24.63 | 2025 | Adstiladrin |
| Ascensia Diabetes Care US INC. | $23.20 | 2025 | |
| Azurity Pharmaceuticals, INC. | $22.21 | 2025 | Azmiro |
| Accord Healthcare, INC. | $22.14 | 2024 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $21.36 | 2025 | Zerbaxa |
| Abbvie INC. | $18.28 | 2024 | |
| Sumitomo Pharma America, INC. | $15.53 | 2025 | Orgovyx |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Esther Finney listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.